Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020.


Journal

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671

Informations de publication

Date de publication:
03 2021
Historique:
received: 13 11 2020
revised: 21 01 2021
accepted: 01 02 2021
pubmed: 19 2 2021
medline: 23 3 2021
entrez: 18 2 2021
Statut: ppublish

Résumé

The four seasonal coronaviruses 229E, NL63, OC43, and HKU1 are frequent causes of respiratory infections and show annual and seasonal variation. Increased understanding about these patterns could be informative about the epidemiology of SARS-CoV-2. Results from PCR diagnostics for the seasonal coronaviruses, and other respiratory viruses, were obtained for 55,190 clinical samples analyzed at the Karolinska University Hospital, Stockholm, Sweden, between 14 September 2009 and 2 April 2020. Seasonal coronaviruses were detected in 2130 samples (3.9 %) and constituted 8.1 % of all virus detections. OC43 was most commonly detected (28.4 % of detections), followed by NL63 (24.0 %), HKU1 (17.6 %), and 229E (15.3 %). The overall fraction of positive samples was similar between seasons, but at species level there were distinct biennial alternating peak seasons for the Alphacoronaviruses, 229E and NL63, and the Betacoronaviruses, OC43 and HKU1, respectively. The Betacoronaviruses peaked earlier in the winter season (Dec-Jan) than the Alphacoronaviruses (Feb-Mar). Coronaviruses were detected across all ages, but diagnostics were more frequently requested for paediatric patients than adults and the elderly. OC43 and 229E incidence was relatively constant across age strata, while that of NL63 and HKU1 decreased with age. Both the Alphacoronaviruses and Betacoronaviruses showed alternating biennial winter incidence peaks, which suggests some type of immune mediated interaction. Symptomatic reinfections in adults and the elderly appear relatively common. Both findings may be of relevance for the epidemiology of SARS-CoV-2.

Identifiants

pubmed: 33601153
pii: S1386-6532(21)00021-4
doi: 10.1016/j.jcv.2021.104754
pmc: PMC7869750
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104754

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

J Clin Virol. 2018 Apr;101:52-56
pubmed: 29427907
Am Rev Respir Dis. 1972 May;105(5):805-11
pubmed: 5020629
Mayo Clin Proc. 2020 Aug;95(8):1701-1703
pubmed: 32753142
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
Epidemiol Infect. 2016 Jul;144(10):2064-76
pubmed: 26931455
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Chaos. 2009 Jun;19(2):023118
pubmed: 19566253
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
J Clin Virol. 2012 Feb;53(2):135-9
pubmed: 22188723
Am J Epidemiol. 1972 Aug;96(2):94-106
pubmed: 4626012
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):363-369
pubmed: 29214503
Swiss Med Wkly. 2020 Mar 16;150:w20224
pubmed: 32176808
N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Cell Rep. 2020 Jun 2;31(9):107725
pubmed: 33500101
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
J Infect Dis. 1974 Mar;129(3):271-6
pubmed: 4816305
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
J Infect Dis. 2020 Jun 16;222(1):9-16
pubmed: 32246136
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
J Infect Dis. 2018 May 5;217(11):1728-1739
pubmed: 29741740
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Nat Rev Immunol. 2020 Nov;20(11):709-713
pubmed: 33024281
J Infect Dis. 2019 Apr 8;219(8):1198-1206
pubmed: 30418633
J Infect Dis. 2020 Jun 16;222(1):17-25
pubmed: 32296837
J Med Virol. 2009 Jan;81(1):167-75
pubmed: 19031448
BMC Infect Dis. 2013 Sep 16;13:433
pubmed: 24040960

Auteurs

Robert Dyrdak (R)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Electronic address: robert.dyrdak@sll.se.

Emma B Hodcroft (EB)

Biozentrum, University of Basel, Basel, Switzerland; Swiss Institute of Bioinformatics, Basel, Switzerland.

Martina Wahlund (M)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Medicine, Infectious Diseases Unit, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Richard A Neher (RA)

Biozentrum, University of Basel, Basel, Switzerland; Swiss Institute of Bioinformatics, Basel, Switzerland.

Jan Albert (J)

Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH